Recently, the 24th World Pharmaceutical Ingredients China Exhibition (CPHI China 2026) concluded at the Shanghai New International Expo Centre. As one of the largest and most professional industry events in Asia’s pharmaceutical ingredients sector, this year’s exhibition gathered over 3,600 pharmaceutical ingredient enterprises globally and attracted hundreds of thousands of domestic and international buyers, establishing a core platform for supply-demand matchmaking, technical exchange, and trade cooperation in the pharmaceutical industry chain. Hebei Messi Biology Co., Ltd., which has been deeply involved in high-end pharmaceutical magnesium salts for over thirty years, showcased its comprehensive range of pharmaceutical-grade magnesium oxide, magnesium carbonate, magnesium sulfate, and magnesium hydroxide products. Relying on reliable product quality, its full-industry-chain advantages, and customized service capabilities, the company experienced highly active consultations on-site, securing numerous orders from both new and existing clients. This participation achieved the threefold goal of brand exposure, channel expansion, and order conversion.
Founded in 1989, Hebei Messi Biology is a national science and technology enterprise and a specialized and sophisticated “SRDI” (Specialized, Refined, Differential, and Innovational) enterprise of Hebei Province. Relying on Tibet’s high-quality magnesium ore resources, the company has established a complete magnesium salt industrial chain integrating mining, deep processing, testing and R&D, and warehousing and logistics. The total annual production capacity of its four major pharmaceutical-grade magnesium salt products has exceeded 150,000 tons. All products strictly comply with domestic and international pharmacopoeia standards such as the Chinese Pharmacopoeia (ChP), USP, and EP. Key indicators such as heavy metals, microorganisms, and purity meet and exceed standard industry entry requirements. These products are widely used in core applications including gastric antacid preparations, magnesium nutritional supplements, laxatives, injection raw materials, and pharmaceutical excipients, making Hebei Messi Biology Co., Ltd. a stable raw material supplier for many domestic pharmaceutical enterprises and health supplement manufacturers.
At this exhibition, Messi Biology highlighted its four signature pharmaceutical-grade magnesium salt products, attracting numerous procurement directors and R&D engineers from domestic and international pharmaceutical companies. The pharmaceutical-grade magnesium oxide neutralizes stomach acid gently with low gas production, making it suitable for chewable tablets and sustained-release formulations. The pharmaceutical-grade magnesium carbonate serves dual functions as a filler and an antacid, acting as an excellent excipient for tablets and capsules. The pharmaceutical-grade magnesium sulfate is suitable for clinical fluid replacement and external physical therapy preparations. The pharmaceutical-grade magnesium hydroxide, a classic gentle antacid raw material, is widely used in gastric mucosal repair drugs. At the exhibition, the company’s technical team provided one-on-one consultations to explain product particle size and crystal form customization solutions, offering sample testing services, pharmacopoeia compliance documents, and GMP production qualification materials on-site to meet the formulation development and mass production needs of different pharmaceutical companies.
During the three-day exhibition, the Messi Biology booth experienced steady foot traffic, receiving over 300 major domestic pharmaceutical groups, health product enterprises, and foreign trade importers/exporters, as well as holding in-depth discussions with professional procurement teams from Southeast Asia, Europe, and the Middle East. Many long-term partners visited the booth to finalize annual incremental supply orders. Dozens of new domestic and international clients requested product samples and scheduled factory visits, with several signing long-term supply framework agreements and batch purchase orders directly on-site, bringing the value of intended cooperation orders to a record high for the company’s exhibition history. Domestic and foreign buyers noted that Messi Biology’s self-production model across the entire industrial chain ensures supply stability, and that its pharmaceutical-grade magnesium salts offer high purity and consistency compared to similar products, serving as viable alternatives to imported raw materials to reduce procurement costs for pharmaceutical companies.
Feng Wenjie, General Manager of Hebei Messi Biology Co., Ltd., stated that the CPHI exhibition is an important window for connecting with the global pharmaceutical market, and the successful securing of orders reflects market recognition of Messi Biology’s pharmaceutical-grade magnesium salt products. Moving forward, the company plans to increase R&D investment in pharmaceutical-grade magnesium salts, optimize green production processes, and continue promoting the domestic substitution of high-end pharmaceutical magnesium salts. Leveraging the dual capacity advantages of its Xingtai production base and Tibet mineral deep processing base, the company aims to provide stable, cost-effective, and fully compliant raw material solutions for pharmaceutical enterprises globally.
The successful conclusion of this CPHI exhibition marks both a demonstration of Hebei Messi Biology Co., Ltd.’s “MESSI” brand strength and a new starting point for its deeper engagement with the global pharmaceutical market. Messi Biology will leverage the cooperative opportunities gained at this exhibition, adhere to its development philosophy of “magnesium as the foundation, quality first,” focus on the pharmaceutical excipients sector, and work with global pharmaceutical partners to support the high-quality development of the international pharmaceutical ingredients industry.